Search

Your search keyword '"Bounameaux, H."' showing total 106 results

Search Constraints

Start Over You searched for: Author "Bounameaux, H." Remove constraint Author: "Bounameaux, H." Database OpenAIRE Remove constraint Database: OpenAIRE
106 results on '"Bounameaux, H."'

Search Results

1. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

2. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

3. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE

4. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

5. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

6. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

7. Predictors of active cancer thromboembolic outcomes

8. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

9. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

10. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

11. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

12. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

13. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

14. Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database

15. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

16. Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry

17. Venous thromboembolism in young adults: Findings from the RIETE registry

18. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

19. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

20. Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years

21. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

22. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

23. Clinical outcome in patients with venous thromboembolism receiving concomitant anticoagulant and antiplatelet therapy

24. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

25. Thrombolytic therapy and outcome of patients with an acute symptomatic pulmonary embolism

26. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

27. Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism

28. D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer

29. Fondaparinux in the initial and long-term treatment of venous thromboembolism

30. Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?

31. Fatal Events in Cancer Patients Receiving Anticoagulant Therapy for Venous Thromboembolism

32. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism

33. Platelet count and outcome in patients with acute venous thromboembolism

34. Unsuspected pulmonary embolism in patients with cancer

35. Clinical presentation and outcome of venous thromboembolism in COPD

36. Thirty-day mortality rate in women with cancer and venous thromboembolism. Findings from the RIETE Registry

37. Clinical significance of a negative D‐dimer level in patients with confirmed venous thromboembolism. Findings from the RIETE Registry

39. Vorapaxar in the secondary prevention of atherothrombotic events

40. Acute venous thromboembolism after non-major orthopaedic surgery or post-traumatic limb immobilisation

41. Oral rivaroxaban for symptomatic venous thromboembolism

42. Venous thromboembolism in patients immobilised at home

43. Sex differences in patients receiving anticoagulant therapy for venous thromboembolism

44. Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism

45. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism

46. Pulmonary embolism and 3-month outcomes in 4036 patients with venous thromboembolism and chronic obstructive pulmonary disease: data from the RIETE registry

47. Oral Apixaban for the Treatment of Acute Venous Thromboembolism

48. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer

49. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer

50. Apixaban for extended treatment of venous thromboembolism

Catalog

Books, media, physical & digital resources